REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/12/2026
Back to search
Official data from USPTO
PENTAPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/13/2026
Trademark type
Combined
Nice classes
1, 3, 5, 10
Filing date
07/07/2019
Registration date
01/12/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/12/2021
Last transaction
01/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
25
Owner location
AESCH BL, CH
Examiner
CORDOVA,RAUL
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the design of a snake shaped like a pentagram with curved edges next to the stylized term "PENTAPHARM".
Holders and representatives
Holders
PENTAPHARM AG
DSM IP Assets B.V.
Representatives
Duane M. Byers NIXON & VANDERHYE PC
Technical classification
Nice Classes
Class 1Class 3Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for industrial and scientific purposesin particular for use in the manufacture of pharmaceutical agents; chemical substances for analyses in laboratories and chemical preparations for scientific purposes; diagnostic preparations for scientific or research use other than for medical use; chemical and biochemical products for the pharmaceuticcosmetic industries; raw materials for use in the manufacture of pharmaceuticalsraw chemical materials for the formulation of pharmaceutical products
Class 3
Cosmeticsalso for beauty and skin care; Cosmetic preparations and substances for the conditioningcaring and appearance of the skinbodyface and hair; cosmetics and skin care products for the prevention of sunburn; sun-tan and sun-screening preparations
Class 5
Pharmaceutical preparations for use in dermatologypharmaceutical preparationspolypeptide fractions of porcine collagen for use in protein stabilization and for use in tissue culture and cell culture; reagents and diagnostic preparations for medical purposes; diagnostic preparations for clinical or medical laboratory use; chemical preparations for pharmaceutical or medical purposes; chemical pharmaceuticals; diagnostic products for medical or veterinary purposesdiagnostic products to measure blood coagulations; diagnostic test kits used for medical analysis of blood
Class 10
Medical apparatus and instrumentstesting apparatus and diagnostic equipment for medical purposes to measure blood coagulation and to diagnosis blood coagulation disorders; measuring devices and diagnostic equipment for medical purposesblood glucose measuring equipmentblood pressure measuring instrument
Publications
History of USPTO decisions and trademark events.
26 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/01/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/27/2020
PUBO
PUBLISHED FOR OPPOSITION
10/27/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/07/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/22/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/18/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2020
ALIE
ASSIGNED TO LIE
08/20/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/02/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/11/2020
GNFR
FINAL REFUSAL E-MAILED
05/11/2020
CNFR
FINAL REFUSAL WRITTEN
05/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2020
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
10/03/2019
GPRA
PRIORITY ACTION E-MAILED
10/03/2019
CPRA
PRIORITY ACTION WRITTEN
10/03/2019
DOCK
ASSIGNED TO EXAMINER
09/24/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2019
NWAP
NEW APPLICATION ENTERED
07/10/2019
Continuous trademark protection
Get notified about every new filing that threatens PENTAPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.